Health-care companies rose as traders rotated into a sector that lagged the broad market in 2023.

Shares of Moderna rallied after analysts at brokerage Oppenheimer boosted their rating on the vaccine developer, saying the outlook for long-term Covid 19 vaccination activity may become clear this year after a slump last year.

Among other vaccine makers, Pfizer rallied.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

01-02-24 1722ET